Skip to main content

Advertisement

Log in

Behavior of prealbumin in the acute phase of polymyalgia rheumatica treated with 6-methylprednisolone

  • Original Contributions
  • Published:
Research in Clinic and Laboratory

Summary

Serum levels of prealbumin, fibronectin, fibrinogen, α1-acid glycoprotein, C-reactive protein, immunoglobulins, and white blood cell count were prospectively studied in 33 patients affected by polymyalgia rheumatica during the first 45 days of treatment with 6-methylprednisolone. Almost all parameters considered, except for fibronectin and IgM, settled within the normal range fairly quickly, while prealbumin showed a specular course compared with the other reactants. This behavior reflected the improvement of clinical symptoms registered in all patients after steroid treatment. Finally, the genesis of the low baseline prealbumin levels found in polymyalgia rheumatica/giant cell arteritis and their behavior during treatment are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Afifi A. A., Azen S. P.: Statistical Analysis: A Computer-Oriented Approach. Academic Press, New York, 1972.

    Google Scholar 

  2. Andersson R., Malmavall B.-E., Bengtsson B.-Å.: Acute phase reactants in the initial phase of giant cell arteritis — Acta med. scand.220, 365, 1986.

    PubMed  CAS  Google Scholar 

  3. Baracos V., Rodemann H. P., Dinarello C. H., Goldberg A. L.: Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1) — New Engl. J. Med.308, 553, 1983.

    PubMed  CAS  Google Scholar 

  4. Beisel W. R.: Mediators of fever and muscle proteolysis — New Engl. J. Med.308, 586, 1983.

    PubMed  CAS  Google Scholar 

  5. Benson M. D., Dwulet F. E.: Prealbumin and retinol-binding protein serum concentrations in the Indiana type hereditary amyloidosis — Arthrit. Rheumat.26, 1493, 1983.

    Article  CAS  Google Scholar 

  6. Bird H. A., Esselinckx W., Dixon A. St. J., Mowat G.: An evaluation of criteria for polymyalgia rheumatica — Ann. rheumat. Dis.38, 434, 1979.

    PubMed  CAS  Google Scholar 

  7. Blake C. C. F., Geisow M. J., Oatley S. J., Rerat C., Rerat B.: Structure of prealbumin: secondary, tertiary, and quaternary interactions determined by Fourier refinement — J. molec. Biol.121, 339, 1978.

    Article  PubMed  CAS  Google Scholar 

  8. Blake C. C. F., Geisow M. J., Swan I. D. A., Rerat C., Rerat B.: Structure of human plasma prealbumin at 2.5 A. A preliminary report on the polypeptide chain conformation, quaternary structure, and thyroxine binding — J. molec. Biol.88, 1, 1974.

    Article  PubMed  CAS  Google Scholar 

  9. Bottiger L. E., Svedberg C. A.: Normal erythrocyte sedimentation rate and age — Brit. med. J.ii, 85, 1967.

    Google Scholar 

  10. Bridgeford P. H., Germain B. F., Lowenstein M., Vasey F. B., Espinoza L. R.: Low erythrocyte sedimentation rate (ESR) in polymyalgia rheumatica — Arthrit. Rheumat.25, S31, 1982. (Abstract).

  11. Chopin N., Geller A., Alexandre J., Dumont G., Befidi R., Lastras J., Lenoir G.: Influence de l’âge sur la concentration sérique des protéines RBP-TBPA et transferrine — Presse méd.12, 959, 1983.

    PubMed  CAS  Google Scholar 

  12. Connors L. H., Gertz M. A., Skinner M., Cohen A. S.: Nephelometric measurement of human serum prealbumin and correlation with acute phase protein CRP and SAA: results in familial amyloid polyneuropathy — J. Lab. clin. Med.104, 538, 1984.

    PubMed  CAS  Google Scholar 

  13. Dickson P. W., Howlett G. J., Schreiber G.: Metabolism of prealbumin in rats and changes induced by acute inflammation — Europ. J. Biochem.129, 289, 1982.

    Article  PubMed  CAS  Google Scholar 

  14. Ellis M. E., Ralston S.: The erythrocyte sedimentation rate in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome — Ann. rheumat. Dis.42, 168, 1983.

    PubMed  CAS  Google Scholar 

  15. Fex G., Felding P.: Factors affecting the concentration of free holoretinol-binding protein in human plasma — Europ. J. clin. Invest.14, 146, 1984.

    Article  PubMed  CAS  Google Scholar 

  16. Freedman D., Pisani R., Purves R.: Statistics. W. W. Norton and Co., New York, 1980.

    Google Scholar 

  17. Gibbs P.: Polymyalgia rheumatica and liver disease — Lanceti, 351, 1974.

    Article  Google Scholar 

  18. Goldsmith B. M., Munson S.: Rate nephelometry and radial immunodiffusion compared for measuring serum prealbumin — Clin. Chem.33, 161, 1987.

    PubMed  CAS  Google Scholar 

  19. Hallen J., Laurell C.-B.: Plasma protein pattern in cirrhosis of the liver — Scand. J. clin. Lab. Invest.29 (Suppl. 124), 97, 1972.

    Google Scholar 

  20. Healey L. A., Wilske K. R.: Manifestation of giant cell arteritis — Med. Clin. N. Amer.61, 261, 1977.

    PubMed  CAS  Google Scholar 

  21. Helliwell M., Coombes E. J., Moody B. J., Batstone G. F.: Thyroxine-binding prealbumin as an index of disease activity or nutritional status in rheumatoid arthritis — Brit. J. Rheumatol.23, 89, 1984.

    Google Scholar 

  22. Huston K. A., Hunder G. G., Lie J. T., Kennedy R. H., Elrebech L. R.: Temporal arteritis: a 25-year epidemiological, clinical and pathological study — Ann. intern. Med.88, 162, 1978.

    PubMed  CAS  Google Scholar 

  23. Ingbar S. H.: Prealbumin: a thyroxine-binding protein of human plasma — Endocrinology63, 256, 1958.

    Article  PubMed  CAS  Google Scholar 

  24. Jones J. G., Hazleman B. L.: Prognosis and management of polymyalgia rheumatica — Ann. rheumat. Dis.40, 1, 1981.

    PubMed  CAS  Google Scholar 

  25. Jouquan J., Pennec Y., Mottier D., Boles J. M., Morin J. F., Youinou P., Garre M.: Protéine vectrice du rétinole, préalbumine et transferrine — Presse méd.12, 1877, 1983.

    PubMed  CAS  Google Scholar 

  26. Kanai M., Raz A., Goodman D. S.: Retinol-binding protein: the transport protein for vitamin A in human plasma — J. clin. Invest.47, 2025, 1968.

    PubMed  CAS  Google Scholar 

  27. Knorring V. J., Wasastjerna C.: Liver involvement in polymyalgia rheumatica — Scand. J. Rheumatol.5, 197, 1976.

    Article  Google Scholar 

  28. Litherland P. G. H., Bromage N. R., Hall R. A.: Thyroxine-binding globulin (TBG) and thyroxine-binding prealbumin (TBPA) measurement, compared with the conventional T3 uptake in the diagnosis of thyroid disease — Clin. chim. Acta122, 345, 1982.

    Article  PubMed  CAS  Google Scholar 

  29. Mallya R. K., Hind C. R. K., Berry H., Pepys M. B.: Serum C-reactive protein in polymyalgia rheumatica: a prospective serial study — Arthrit. Rheumat.28, 383, 1985.

    Article  CAS  Google Scholar 

  30. McKone T. K., Davis A. T., Dean R. E.: Fibronectin. A new nutritional parameter — Amer. Surg.51, 336, 1985.

    CAS  Google Scholar 

  31. Park J. R., Jones J. G., Hazleman B. L.: Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis — Ann. rheumat. Dis.40, 493, 1981.

    PubMed  CAS  Google Scholar 

  32. Richter M., Coughlan R., Panayi G., Gordon Y.: Is there more than one signal for an acute phase response? — J. Rheumatol.12, 1048, 1985.

    PubMed  CAS  Google Scholar 

  33. Richter M., Coughlan R., Trull A., Panayi G. S.: Prealbumin as a sensitive measure of disease activity — Ann. rheumat. Dis.42, 220, 1983. (Abstract).

    Google Scholar 

  34. Richter M. B., Woo P., Panayi G. S., Trull A., Hunger A., Shepherd P.: The effect of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis — Clin. exp. Immunol.53, 51, 1983.

    PubMed  CAS  Google Scholar 

  35. Scott R. L., Sohmer P. R., MacDonald M. B. G.: The effect of starvation and repletion on plasma fibronectin in man — J. Amer. med. Ass.248, 2025, 1982.

    Article  CAS  Google Scholar 

  36. Shetty P. S., Watrasiewicz K. E., Jung R. T., James W. P. T.: Rapid-turnover transport proteins: an index of subclinical protein-energy malnutrition — Lancetii, 230, 1979.

    Article  Google Scholar 

  37. Skredf S., Blomhoff J. P., Elgjo K., Gjone E.: Serum proteins in diseases of the liver — Scand. J. clin. Lab. Invest.35, 399, 1975.

    Article  Google Scholar 

  38. Smith F. R., Goodman D. S.: The effect of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma — J. clin. Invest.50, 2426, 1971.

    Article  PubMed  CAS  Google Scholar 

  39. Soelberg-Sorensen P., Lorenzen I.: Giant cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients — Acta med. scand.201, 207, 1977.

    Google Scholar 

  40. Sokolov E. L., Woeber K. A., Purdy R. H., Holloway M. T., Ingbar S. H.: Preparation of I131-labeled human serum prealbumin and its metabolism in normal and sick patients — J. clin. Invest.44, 1600, 1965.

    Article  Google Scholar 

  41. Teppo A. M., Maury C. P. J.: Serum prealbumin, transferrin and immunoglobulins in fatty liver, alcoholic cirrhosis and primary biliary cirrhosis — Clin. chim. Acta129, 279, 1983.

    Article  PubMed  CAS  Google Scholar 

  42. Winer B. J.: Statistical Principles in Experimental Design. McGraw-Hill, New York, 1971.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Puccetti, L., Lucchetti, A., Barbieri, P. et al. Behavior of prealbumin in the acute phase of polymyalgia rheumatica treated with 6-methylprednisolone. Res. Clin. Lab. 19, 251–258 (1989). https://doi.org/10.1007/BF02871814

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02871814

Key-words

Navigation